Cannabis Stock Movers For May 13, 2022
GAINERS:
Heritage Cannabis Holding (OTC:HERTF) shares closed up 51.28% at $0.06
New Jersey Senators Talk High Medical Marijuana Prices And More With Top CRC Officials
New Jersey Senate president Nick Scutari (D) and Sen.
Despite Recent Headwinds, U.S. Cannabis Industry “Doing Just Fine”, According To Brady Cobb
In this week’s Trade To Black Podcast, TDR Founder Shadd Dales and contributor Anthony Varrell interviewed leading U.S. cannabis entrepreneur, advocate, and current CEO of Sunburn Cannabis, Brady Cobb. On the agenda were core agenda items of interest to cannabis investors, including the seemingly improving odds of SAFE Banking passage, how the U.S.
Green Thumb Industries Analyst On Q1 Earnings: Cannabis Grower Has Enough Cash To Fuel Growth
Green Thumb Industries Inc. (OTCQX: GTBIF) (CSE: GTII) reported its
Needham Maintains Buy on Green Thumb Industries, Lowers Price Target to $26
Needham analyst Matt McGinley maintains Green Thumb Industries (OTC:GTBIF) with a Buy and lowers the price target from $33 to $26.
This Cannabis MSO Is Well-Placed To Benefit From NJ Rec Market Launch, Analyst Thoughts Ahead Q1 Earnings
Green Thumb Industries (CSE: GTII) (OTC: GTBIF) is scheduled to report its first-quarter earnings report on Wednesday.
Cantor Fitzgerald Maintains Overweight on Green Thumb Industries, Lowers Price Target to $39
Cantor Fitzgerald analyst Pablo Zuanic maintains Green Thumb Industries (OTC:GTBIF) with a Overweight and lowers the price target from $41 to $39.
Cannabis Stocks Still Down As Federal Legalization Drags On: Will The SAFE Act Rescue Them, Or Something Else?
There’s no doubt that important changes in the cannabis industry, such as legalization efforts, directly impact weed stocks.
How Much Did New Jerseyans Spend On First Day Of Cannabis Sales? Yes, There Was Enough Weed For Everyone
Last week New Jersey kicked off long-awaited recreational cannabis sales.
EXCLUSIVE: Ricky Sandler Sees ‘Incredible Opportunity’ In Cannabis, Especially These 4 Pot Stocks
Institutions have been completely unwilling to invest in the evolving cannabis space — with the exception of Eminence Capital.